Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 3 ( May-June, 2024 ) > List of Articles

REVIEW ARTICLE

Diagnosing Osteoporosis at Menopause: Options Available Apart from DEXA

Ruchika Garg, Prabhat Agrawal, Prashant Gupta, Kavita Chaudhary

Keywords : Bone, Osteoporosis, Quantitative computed tomography, Trabecular bone score

Citation Information : Garg R, Agrawal P, Gupta P, Chaudhary K. Diagnosing Osteoporosis at Menopause: Options Available Apart from DEXA. J South Asian Feder Obs Gynae 2024; 16 (3):282-284.

DOI: 10.5005/jp-journals-10006-2414

License: CC BY-NC 4.0

Published Online: 29-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Bone resistance to fractures is helped by micro and macrostructures, bone marrow density (BMD), and adjacent tissues (e.g., cartilages, muscles). Such complementary factors shall be analyzed when BMD alone does not explain increased fracture risk (e.g., the presence of desmophytes in the vertebral column). Initial evaluation of fracture risk can be carried out automatically based on a single abdomen or chest computed tomography (CT) when FRAX without BMD is not available. As CT has high radiation exposure risk and cost concerns opportunistic screening of osteoporosis can be done when CT is done for other health conditions (from chest, abdomen, pelvis, and spine). Trabecular bone score (TBS) can assess patients with osteophytes as osteophytes lead to inaccurate BMD measurements. Trabecular bone score and quantitative ultrasound assess different characteristics of bones. Magnetic resonance imaging (MRI) may allow the identification of patients with fracture risk not detected by DXA.


PDF Share
  1. Borges JLC, Sousa da Silva M, Ward RJ, et al. Repeating vertebral fracture assessment: 2019 ISCD official position J Clin Densitom 019;22(4):484–488. DOI: 10.1016/j.jocd.2019.07.005.
  2. Gregson CL, Armstrong DJ, Bowden J, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 2022;17(1):58. DOI:10.1007/s11657-022-01061-5.
  3. McCloskey EV, Oden A, Harvey NC, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 2016;31(5):940–948. DOI: 10.1002/jbmr.2734.
  4. Guglielmi G, Floriani I, Torri V, et al. Effect of spinal degenerative changes on volumetric bone mineral density of the central skeleton as measured by quantitative computed tomography. Acta Radiol 2005;46(3):269–275. DOI: 10.1080/02841850510012661.
  5. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003;349(13):1207–1215. DOI: 10.1056/NEJMoa031975.
  6. Pan Y, Shi D, Wang H, et al. Automatic opportunistic osteoporosis screening using low-dose chest computed tomography scans obtained for lung cancer screening. Eur Radiol 2020;30(7):4107–4116. DOI: 10.1007/s00330-020-06679-y.
  7. Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, et al. Current status of the diagnosis and management of osteoporosis. Int J Mol Sci 2022;23(16):9465. DOI: 10.3390/ijms23169465.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.